COVID-19, nausea, and vomiting.

J Gastroenterol Hepatol · 2021 · PMC7537541 · PMID 32955126

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In human ARDS plasma IL‐6, increases and interestingly treatment with recombinant human ACE2 showed a trend to decrease IL‐6, 113 an effect if repeated in COVID‐19 patients may be beneficial to the digestive tract as well as any effects of cytokines on nausea, vomiting, and food intake. b) Interaction between SARS‐CoV‐2 and ACE2 in both the respiratory and digestive tracts will elevate plasma AII co

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.